iSpecimen - ISPC Net earnings per one share for the last twelve months

iSpecimen Inc (ISPC) - corporate logo

Rising demand for biomaterials for AI-driven drugs and the development of the iSpecimen (ISPC) marketplace are driving revenue, which is reflected in the YoY EPS dynamics on a rolling 12-month basis on GURU.Markets, where 86.60 represents the latest level. Long-term budgets from pharma behemoths ensure business resilience by minimizing cyclicality, while a diversified supplier network protects the company from the risks associated with owning biobanks.

iSpecimen Inc (ISPC) Net earnings per share (EPS TTM): for the period 02/11/2024 - 11/15/2026

iSpecimen Corp - analytical breakdowns and key metrics (ISPC)

- stock quotes and analyst forecast:
Quote Chart ispecimen.com|ISPC - Analyst Consensus Forecast
- issuer market value details:
Market Value iSpecimen Corp|ISPC - Enterprise Value
- company book value details:
Accounting Value per Share iSpecimen|ISPC - Book Capitalization|Market Capitalization to Book Value ispecimen.com|ISPC - Aggregate Company Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio iSpecimen Inc.|ISPC - Long-Term Debt to Capital|Current Liabilities to Capital iSpecimen|ISPC - Company Debts|Debt to Book Value Ratio iSpecimen|ISPC - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings iSpecimen|Interim Coverage Ratio ispecimen.com
- earnings and market multiples details:
ISPC - Company Net Income|Net Profit Forecast iSpecimen Inc.|ISPC - P/E Multiple|Projected Price to Earnings iSpecimen Inc|ISPC - Price/Earnings to Growth Multiple|Total Company Value to Operating Income Before Depreciation Ratio iSpecimen Corp|ISPC - Operating profit EBITDA|Net earnings per share for the last four quarters iSpecimen|ISPC - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months ispecimen.com|ISPC - Earnings per share growth in current year|Net earnings per share change forecast for next year iSpecimen Inc.
- sales and revenue indicators:
ISPC - Revenue and Sales Volume|Company Future Sales Volume ispecimen.com|ISPC - P/S Multiple|Market Cap to Expected Sales Ratio iSpecimen|ISPC - Revenue Growth YoY (Last 12 Months)
Initial company analysis:iSpecimen Inc., ISPC
Manufactured product of iSpecimen Inc

This indicator measures the percentage change in rolling annual earnings per share, allowing for an assessment of capital generation efficiency and business scaling rates. By analyzing the YoY ttm growth of net income per share, an investor can see the impact of regulatory barriers and IT integration complexities at iSpecimen Inc. (ISPC), which determine the company's margin stability amidst stringent medical legislation.

Direct competitors

Net earnings per one share for the last twelve months Veeva Systems Inc|DOCS: Net earnings per share (EPS TTM)|HQY: Earnings per share for the last four quarters|WAY (Waystar Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months corvel.com CRVL|Net earnings per share (EPS TTM) PRVA|HURN (Huron) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) CERT (Certara Inc)|Omnicell Health - Earnings per share for the last twelve months|GoodRx Holdings, Inc. - Net earnings per share (EPS TTM)|SDGR (Schrodinger, Inc.) - Earnings per share for the last 12 months|PHR: Net earnings per share (EPS TTM)|Omada Health, Inc. (OMDA) - Net earnings per share (EPS TTM)|EVH (Evolent Health Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months HealthStream Corp HSTM|Net earnings per share (EPS TTM) DH|Net earnings per share for the last 12 months consensus.com CCSI|Net earnings per share (EPS TTM) AGL (agilon health)|Earnings per share for the trailing year ABSI|SY - Earnings per share for the last twelve months|NRC - Net earnings per share (EPS TTM)|SPOK (Spok Holdings, Inc.) - Net earnings per share for the last 12 months|optimizerx.com - Earnings per share for the trailing year|Net earnings per share for the last 12 months TBRG|Simulations Plus Corp (SLP) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months SOPH (Sophia Genetics)|HCAT (Health Catalyst, Inc) - Earnings per share for the trailing year|Earnings per share for the last twelve months CareCloud Corp CCLD|RSSS: Earnings per share for the last 12 months|DLHC: Net earnings per share for the last 12 months|onemednet.com - Earnings per share for the last four quarters|SCNX (Scienture Holdings Inc.) - Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Healthcare Triangle Corp (HCTI)|Earnings per share for the last twelve months Bullfrog AI|Net earnings per share for the last 12 months SCWorx Corp. (WORX)|Net earnings per share (EPS TTM) MSPR|Earnings per share for the last four quarters ICCT|Earnings per share for the last twelve months TRxADE Health Corp MEDS|ORGS - Net earnings per share for the last 12 months|R1 RCM - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Sharecare, Inc.|STRM: Net earnings per share (EPS TTM)|Syra Health Corp - Earnings per share for the trailing year|Earnings per share for the last twelve months apollomed.net|Earnings per share for the last 12 months MODN (Model N Corp)|Earnings per share for the last twelve months nextgen.com (NXGN)